-
Alternative name
FLJ95174, FLJ97302, Galactowaldenase, GALE, SDR1E1, UDP glucose 4 epimerase, UDP-galactose-4-epimerase antibody
-
Catalog
A003309
-
Size100μg
-
Formliquid
-
Purity≥95% as determined by SDS-PAGE
-
StoragePBS with 0.02% sodium azide and 50% glycerol pH 7.3 , -20℃ for 24 months (Avoid repeated freeze / thaw cycles.)
-
ClonalityPolyclonal Antibody
-
Host Rabbit
-
Species ReactivityHuman,Mouse ,Rat
-
Applications Tested/SuitableELISA,WB,IHC
-
PurificationImmunogen affinity purified
-
ImmunogenUDP-galactose-4-epimerase
-
IHCImmunohistochemistry of paraffin-embedded human malignant melanoma using A003309(GALE antibody) at dilution of 1:100
-
Western BlotA375 cells were subjected to SDS PAGE followed by western blot with A003309(GALE antibody) at dilution of 1:300
-
Recommended dilutionWB : 1:200-1:1000
-
Product Description specificalCatalyzes two distinct but analogous reactions: the reversible epimerization of UDP-glucose to UDP-galactose and the reversible epimerization of UDP-N-acetylglucosamine to UDP-N- acetylgalactosamine. The reaction with UDP-Gal plays a critical role in the Leloir pathway of galactose catabolism in which galactose is converted to the glycolytic intermediate glucose 6- phosphate. It contributes to the catabolism of dietary galactose and enables the endogenous biosynthesis of both UDP-Gal and UDP- GalNAc when exogenous sources are limited. Both UDP-sugar interconversions are important in the synthesis of glycoproteins and glycolipids.
-
Gene nameGALE
-
Uniprot IDQ14376
-
Observed M.W.38 kDa
-